Casper-Emil T. Pedersen PhD , Anders Eliasen PhD , Kasper Fischer-Rasmussen PhD , Yang Luo PhD , Frederikke Skov MD , Astrid Sevelsted PhD , Jonathan Thorsen MD, PhD , Jens-Ulrik Stæhr Jensen MD , Jørgen Vestbo MD , Thomas Werge PhD , Andreanne Morin PhD , Carole Ober PhD , Morten A. Rasmussen PhD , George Davey Smith MD, DSc, FRS , Jakob Stokholm MD, PhD , Bo Chawes MD, PhD, DMSc , Klaus Bønnelykke MD, PhD
{"title":"Genetic risk for adult obstructive lung function and its early life associations","authors":"Casper-Emil T. Pedersen PhD , Anders Eliasen PhD , Kasper Fischer-Rasmussen PhD , Yang Luo PhD , Frederikke Skov MD , Astrid Sevelsted PhD , Jonathan Thorsen MD, PhD , Jens-Ulrik Stæhr Jensen MD , Jørgen Vestbo MD , Thomas Werge PhD , Andreanne Morin PhD , Carole Ober PhD , Morten A. Rasmussen PhD , George Davey Smith MD, DSc, FRS , Jakob Stokholm MD, PhD , Bo Chawes MD, PhD, DMSc , Klaus Bønnelykke MD, PhD","doi":"10.1016/j.jaci.2025.06.035","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Chronic obstructive pulmonary disease may partly originate in early life under influence from prenatal or early postnatal risk factors, including genetic predisposition.</div></div><div><h3>Objectives</h3><div>We investigated the extent to which the genetic predisposition to adult obstructive lung function manifests already at birth and throughout childhood in terms of impaired lung function, bronchial responsiveness, and asthma-related symptoms.</div></div><div><h3>Methods</h3><div>We constructed a polygenic risk score (PRS) for adult obstructive lung function (FEV<sub>1</sub>/forced vital capacity [FVC]) and associated it with neonatal and childhood lung function, bronchial responsiveness, asthma, and respiratory tract infections in the COPSAC (Copenhagen Prospective Studies on Asthma in Childhood) birth cohorts, and with hospitalization for wheeze, asthma, and infections in 114,283 unrelated individuals from the The Lundbeck Foundation Initiative for Integrative Psychiactric Research (iPSYCH) cohort.</div></div><div><h3>Results</h3><div>The FEV<sub>1</sub>/FVC PRS was associated with obstructive lung function shortly after birth (eg, neonatal FEV<sub>0.5</sub>/FVC [β: −0.20; 95% CI: −0.31 to −0.09; <em>P</em> < .0003]), with continued progression into adolescence. A higher PRS was also linked to an increased risk of severe wheeze/asthma episodes (odds ratio: 1.24; 95% CI: 1.19-1.29; <em>P</em> = 1.6 × 10<sup>−26</sup>) and lower respiratory tract infections (odds ratio: 1.09; 95% CI: 1.06-1.12; <em>P</em> = 3.5 × 10<sup>−8</sup>) requiring hospitalization, which was evident a few months after birth. In COPSAC<sub>2000</sub>, there was no evidence of asthma exacerbations mediating the association between FEV<sub>1</sub>/FVC PRS and lung function by age 18 years.</div></div><div><h3>Conclusions</h3><div>Genetic predisposition to obstructive lung function was evident shortly after birth in terms of impaired neonatal lung function and increased susceptibility to severe wheeze, asthma, and lower respiratory tract infections. This indicates prenatal life and early childhood as a window of opportunity for improving lung health in adulthood.</div></div>","PeriodicalId":14936,"journal":{"name":"Journal of Allergy and Clinical Immunology","volume":"156 4","pages":"Pages 937-947"},"PeriodicalIF":11.2000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Allergy and Clinical Immunology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0091674925007791","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Chronic obstructive pulmonary disease may partly originate in early life under influence from prenatal or early postnatal risk factors, including genetic predisposition.
Objectives
We investigated the extent to which the genetic predisposition to adult obstructive lung function manifests already at birth and throughout childhood in terms of impaired lung function, bronchial responsiveness, and asthma-related symptoms.
Methods
We constructed a polygenic risk score (PRS) for adult obstructive lung function (FEV1/forced vital capacity [FVC]) and associated it with neonatal and childhood lung function, bronchial responsiveness, asthma, and respiratory tract infections in the COPSAC (Copenhagen Prospective Studies on Asthma in Childhood) birth cohorts, and with hospitalization for wheeze, asthma, and infections in 114,283 unrelated individuals from the The Lundbeck Foundation Initiative for Integrative Psychiactric Research (iPSYCH) cohort.
Results
The FEV1/FVC PRS was associated with obstructive lung function shortly after birth (eg, neonatal FEV0.5/FVC [β: −0.20; 95% CI: −0.31 to −0.09; P < .0003]), with continued progression into adolescence. A higher PRS was also linked to an increased risk of severe wheeze/asthma episodes (odds ratio: 1.24; 95% CI: 1.19-1.29; P = 1.6 × 10−26) and lower respiratory tract infections (odds ratio: 1.09; 95% CI: 1.06-1.12; P = 3.5 × 10−8) requiring hospitalization, which was evident a few months after birth. In COPSAC2000, there was no evidence of asthma exacerbations mediating the association between FEV1/FVC PRS and lung function by age 18 years.
Conclusions
Genetic predisposition to obstructive lung function was evident shortly after birth in terms of impaired neonatal lung function and increased susceptibility to severe wheeze, asthma, and lower respiratory tract infections. This indicates prenatal life and early childhood as a window of opportunity for improving lung health in adulthood.
期刊介绍:
The Journal of Allergy and Clinical Immunology is a prestigious publication that features groundbreaking research in the fields of Allergy, Asthma, and Immunology. This influential journal publishes high-impact research papers that explore various topics, including asthma, food allergy, allergic rhinitis, atopic dermatitis, primary immune deficiencies, occupational and environmental allergy, and other allergic and immunologic diseases. The articles not only report on clinical trials and mechanistic studies but also provide insights into novel therapies, underlying mechanisms, and important discoveries that contribute to our understanding of these diseases. By sharing this valuable information, the journal aims to enhance the diagnosis and management of patients in the future.